Cargando…

A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma

BACKGROUND: Tumor metastasis is one of the main causes of the high mortality of hepatocellular carcinoma (HCC). E-Twenty Six variant gene 6 (ETV6) is a strong transcriptional repressor, associated with the development and progression of tumors. However, the exact role and underlying mechanism of ETV...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Chunmei, Gao, Chao, Zhao, Dongting, Li, Jiahui, Wang, Jinxia, Sun, Xujuan, Liu, Qinlong, Hao, Lihong, Greenaway, Frederick T., Tian, Yuxiang, Liu, Shuqing, Sun, Ming-Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178969/
https://www.ncbi.nlm.nih.gov/pubmed/32326970
http://dx.doi.org/10.1186/s13046-020-01559-1
_version_ 1783525574868729856
author Guo, Chunmei
Gao, Chao
Zhao, Dongting
Li, Jiahui
Wang, Jinxia
Sun, Xujuan
Liu, Qinlong
Hao, Lihong
Greenaway, Frederick T.
Tian, Yuxiang
Liu, Shuqing
Sun, Ming-Zhong
author_facet Guo, Chunmei
Gao, Chao
Zhao, Dongting
Li, Jiahui
Wang, Jinxia
Sun, Xujuan
Liu, Qinlong
Hao, Lihong
Greenaway, Frederick T.
Tian, Yuxiang
Liu, Shuqing
Sun, Ming-Zhong
author_sort Guo, Chunmei
collection PubMed
description BACKGROUND: Tumor metastasis is one of the main causes of the high mortality of hepatocellular carcinoma (HCC). E-Twenty Six variant gene 6 (ETV6) is a strong transcriptional repressor, associated with the development and progression of tumors. However, the exact role and underlying mechanism of ETV6 in HCC remain unclear. METHODS: Western blotting, quantitative real-time PCR and immunohistochemistry were used to detect the expression levels of ETV6, CRKL (v-crk sarcoma virus CT10 oncogene homologue (avian)-like) and miR-429 in HCC tissues and cells; Transwell chamber and F-actin cytoskeleton staining assay to examine the effects of ETV6 and CRKL deregulation on the migration, invasion and cytoskeleton of HCC cells; Co-immunoprecipitation assay to determine the interaction between CRKL and ETV6; Chromatin immunoprecipitation assay to investigate the interaction between ETV6 and miR-429. RESULTS: We established a novel ETV6-miR-429-CRKL regulatory circuitry contributes to HCC metastasis. ETV6 and CRKL were frequently increased, while miR-429 was downregulated in both hepatocarcinoma tissues and hepatocarcinoma cells. Moreover, ETV6 upregulation was positively correlated with CRKL upregulation, and two negative correlations were also established for ETV6 and CRKL upregulation with miR-429 downregulation in both hepatocarcinoma patients’ tumorous tissues and hepatocarcinoma cells. Functional investigations revealed that overexpression and knockdown of ETV6 was remarkably effective in promoting and suppressing HCC cell migration, invasion, cytoskeleton F-actin expression and arrangement, whereas, CRKL overexpression exhibited similar effects to the overexpression of ETV6. Mechanistically, ETV6 negatively regulates miR-429 expression by directly binding to the promoter region of miR-429; miR-429 negatively regulates CRKL expression by selectively targeting CRKL-3′-UTR; ETV6 directly binds to CRKL and positively regulates its expression, which in turn CRKL positively regulates ETV6 expression. CONCLUSIONS: Our data demonstrated that ETV6 promotes migration and invasion of HCC cells by directly binding to promoter region of miR-429 via modulating CRKL expression. The newly identified ETV6-miR-429-CRKL regulatory circuitry contributes to the aggressiveness of HCC, which provides new clues for fundamental research on diagnosis and treatment parameters for HCC.
format Online
Article
Text
id pubmed-7178969
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-71789692020-04-26 A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma Guo, Chunmei Gao, Chao Zhao, Dongting Li, Jiahui Wang, Jinxia Sun, Xujuan Liu, Qinlong Hao, Lihong Greenaway, Frederick T. Tian, Yuxiang Liu, Shuqing Sun, Ming-Zhong J Exp Clin Cancer Res Research BACKGROUND: Tumor metastasis is one of the main causes of the high mortality of hepatocellular carcinoma (HCC). E-Twenty Six variant gene 6 (ETV6) is a strong transcriptional repressor, associated with the development and progression of tumors. However, the exact role and underlying mechanism of ETV6 in HCC remain unclear. METHODS: Western blotting, quantitative real-time PCR and immunohistochemistry were used to detect the expression levels of ETV6, CRKL (v-crk sarcoma virus CT10 oncogene homologue (avian)-like) and miR-429 in HCC tissues and cells; Transwell chamber and F-actin cytoskeleton staining assay to examine the effects of ETV6 and CRKL deregulation on the migration, invasion and cytoskeleton of HCC cells; Co-immunoprecipitation assay to determine the interaction between CRKL and ETV6; Chromatin immunoprecipitation assay to investigate the interaction between ETV6 and miR-429. RESULTS: We established a novel ETV6-miR-429-CRKL regulatory circuitry contributes to HCC metastasis. ETV6 and CRKL were frequently increased, while miR-429 was downregulated in both hepatocarcinoma tissues and hepatocarcinoma cells. Moreover, ETV6 upregulation was positively correlated with CRKL upregulation, and two negative correlations were also established for ETV6 and CRKL upregulation with miR-429 downregulation in both hepatocarcinoma patients’ tumorous tissues and hepatocarcinoma cells. Functional investigations revealed that overexpression and knockdown of ETV6 was remarkably effective in promoting and suppressing HCC cell migration, invasion, cytoskeleton F-actin expression and arrangement, whereas, CRKL overexpression exhibited similar effects to the overexpression of ETV6. Mechanistically, ETV6 negatively regulates miR-429 expression by directly binding to the promoter region of miR-429; miR-429 negatively regulates CRKL expression by selectively targeting CRKL-3′-UTR; ETV6 directly binds to CRKL and positively regulates its expression, which in turn CRKL positively regulates ETV6 expression. CONCLUSIONS: Our data demonstrated that ETV6 promotes migration and invasion of HCC cells by directly binding to promoter region of miR-429 via modulating CRKL expression. The newly identified ETV6-miR-429-CRKL regulatory circuitry contributes to the aggressiveness of HCC, which provides new clues for fundamental research on diagnosis and treatment parameters for HCC. BioMed Central 2020-04-23 /pmc/articles/PMC7178969/ /pubmed/32326970 http://dx.doi.org/10.1186/s13046-020-01559-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Guo, Chunmei
Gao, Chao
Zhao, Dongting
Li, Jiahui
Wang, Jinxia
Sun, Xujuan
Liu, Qinlong
Hao, Lihong
Greenaway, Frederick T.
Tian, Yuxiang
Liu, Shuqing
Sun, Ming-Zhong
A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma
title A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma
title_full A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma
title_fullStr A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma
title_full_unstemmed A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma
title_short A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma
title_sort novel etv6-mir-429-crkl regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178969/
https://www.ncbi.nlm.nih.gov/pubmed/32326970
http://dx.doi.org/10.1186/s13046-020-01559-1
work_keys_str_mv AT guochunmei anoveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma
AT gaochao anoveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma
AT zhaodongting anoveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma
AT lijiahui anoveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma
AT wangjinxia anoveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma
AT sunxujuan anoveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma
AT liuqinlong anoveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma
AT haolihong anoveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma
AT greenawayfrederickt anoveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma
AT tianyuxiang anoveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma
AT liushuqing anoveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma
AT sunmingzhong anoveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma
AT guochunmei noveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma
AT gaochao noveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma
AT zhaodongting noveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma
AT lijiahui noveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma
AT wangjinxia noveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma
AT sunxujuan noveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma
AT liuqinlong noveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma
AT haolihong noveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma
AT greenawayfrederickt noveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma
AT tianyuxiang noveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma
AT liushuqing noveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma
AT sunmingzhong noveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma